Study of Vonoprazan-based triple theary for eradication of helicobacter pylori
Not Applicable
- Conditions
- gastritis with helicobacter pylori infection
- Registration Number
- JPRN-UMIN000022846
- Lead Sponsor
- Onaka Clinic
- Brief Summary
The success rate of vonoprazan-based triple thearpy was 91.7% at the primary eradication compare to 80.9% with PPI. It is significant better result.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Success rate of the eradication therapy after one month later by urea breath test
- Secondary Outcome Measures
Name Time Method Mortality and morbidity of the eradication therapy